Lundbeck
HLUN-B.CO
#2404
Rank
S$8.25 B
Marketcap
$8.64
Share price
5.14%
Change (1 day)
23.46%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Cash on Hand

Cash on Hand as of June 2024 : S$1.19 Billion

According to Lundbeck 's latest financial reports the company has S$1.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lundbeck - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.97 B48.38%
2022-12-31S$0.66 B40.8%
2021-12-31S$0.46 B-45.34%
2020-12-31S$0.85 B40.94%
2019-12-31S$0.60 B-56.16%
2018-12-31S$1.38 B75.16%
2017-12-31S$0.79 B74.51%
2016-12-31S$0.45 B44.09%
2015-12-31S$0.31 B-60.18%
2014-12-31S$0.79 B-42.39%
2013-12-31S$1.37 B66.7%
2012-12-31S$0.82 B-7.32%
2011-12-31S$0.88 B64.81%
2010-12-31S$0.53 B-1.15%
2009-12-31S$0.54 B-47.54%
2008-12-31S$1.04 B108.59%
2007-12-31S$0.49 B55.99%
2006-12-31S$0.31 B164.9%
2005-12-31S$0.12 B-24.95%
2004-12-31S$0.16 B